Podcast #209 · 14 Jan 2025
Management of Bladder Cancer: Insights from Community Practice
- Bacillus Calmette-Guérin (BCG)
- Urologic Oncology
- Non-Muscle Invasive Bladder Cancer (NMIBC)
- Service Line Building
- Cystectomy
- Intravesical Therapy
- Bladder Cancer
Are you a private practice urologist looking to build your bladder cancer service lines? In this episode of the BackTable Urology Podcast, Dr. Tom Jayram, urologist from Nashville joins host Dr. Aditya Bagrodia to discuss the latest advancements in non-muscle invasive bladder cancer treatment. The conversation focuses on the unique experiences and practical considerations in managing this complex condition in the community setting.
This podcast is supported by
Timestamps
Resources
More about this episode
The two urologic oncologists share their decision-making process for different therapies such as BCG, gemcitabine-doxorubicin, and Adstiladrin. The conversation also touches on the challenges of integrating new technologies into practice, managing the BCG shortage, and the role of multidisciplinary care. They discuss patient-centered care and the potential for personalized treatment plans. Finally, Dr. Jayram reflects on the lessons he has learned from his own practice, offering a unique insight into the differences between academic and community urology.